Literature DB >> 22391684

Evaluation of the effects of hyperbaric oxygen therapy for spinal cord lesion in correlation with the moment of intervention.

A F Cristante1, M L Damasceno, T E P Barros Filho, R P de Oliveira, R M Marcon, I D da Rocha.   

Abstract

STUDY
DESIGN: Experimental, controlled, animal study.
OBJECTIVES: To evaluate the functional effect of hyperbaric oxygen therapy administered shortly, one day after, and no intervention (control) in standardized experimental spinal cord lesions in Wistar rats.
SETTING: São Paulo, Brazil.
METHODS: In all, 30 Wistar rats with spinal cord lesions were divided into three groups: one group was submitted to hyperbaric oxygen therapy beginning half an hour after the lesion and with a total of 10 one-hour sessions, one session per day, at 2 atm; the second received the same treatment, but beginning on the day after the lesion; and the third received no treatment (control). The Basso, Beattie and Bresnahan scales were used for functional evaluation on the second day after the lesion and then weekly, until being killed 1 month later.
RESULTS: There were no significant differences between the groups in the functional analysis on the second day after the lesion. There was no functional difference comparing Groups 1 and 2 (treated shortly after or one day after) in any evaluation moment. On the 7th day, as well as on the 21st and 28th postoperative days, the evaluation showed that groups 1 and 2 performed significantly better than the control group (receiving no therapy).
CONCLUSION: Hyperbaric chamber therapy is beneficial in the functional recovery of spinal cord lesions in rats, if it is first administered just after spinal cord injury or within 24 h.

Entities:  

Mesh:

Year:  2012        PMID: 22391684     DOI: 10.1038/sc.2012.16

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  6 in total

1.  Protective effects of hyperbaric oxygen treatment against spinal cord injury in rats via toll-like receptor 2/nuclear factor-κB signaling.

Authors:  Jiewen Tan; Fang Zhang; Fang Liang; Yong Wang; Zhuo Li; Jing Yang; Xuehua Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  Effects of ganglioside G(M1) and erythropoietin on spinal cord lesions in rats: functional and histological evaluations.

Authors:  Raphael Martus Marcon; Alexandre Fogaça Cristante; Tarcísio Eloy Pessoa de Barros; Ricardo Ferreira; Gustavo Bispo Dos Santos
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

3.  Effects of tacrolimus and erythropoietin in experimental spinal cord lesion in rats: functional and histological evaluation.

Authors:  P R de Mesquita Coutinho; A F Cristante; T E P de Barros Filho; R Ferreira; G B Dos Santos
Journal:  Spinal Cord       Date:  2015-10-20       Impact factor: 2.772

4.  Evaluation of the effects of erythropoietin and interleukin-6 in rats submitted to acute spinal cord injury.

Authors:  Alderico Girão Campos de Barros; Alexandre Fogaça Cristante; Gustavo Bispo Dos Santos; Renato José Mendonça Natalino; Ricardo José Rodriguez Ferreira; Tarcísio Eloy Pessoa de Barros-Filho
Journal:  Clinics (Sao Paulo)       Date:  2019-08-19       Impact factor: 2.365

Review 5.  Therapeutic approaches for spinal cord injury.

Authors:  Alexandre Fogaça Cristante; Tarcísio Eloy Pessoa de Barros Filho; Raphael Martus Marcon; Olavo Biraghi Letaif; Ivan Dias da Rocha
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

6.  Hyperbaric Oxygen and Ginkgo Biloba Extract Ameliorate Cognitive and Memory Impairment via Nuclear Factor Kappa-B Pathway in Rat Model of Alzheimer's Disease.

Authors:  Li-Da Zhang; Li Ma; Li Zhang; Jian-Guo Dai; Li-Gong Chang; Pei-Lin Huang; Xiao-Qiang Tian
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.